PURPOSE: Combining specific and quantitative F-19 magnetic resonance imaging (MRI) with sensitive and convenient optical imaging provides complementary information about the distribution and viability of transplanted pancreatic islet grafts. In this study, pancreatic islets (PIs) were labeled with positively charged multimodal nanoparticles based on poly(lactic-co-glycolic acid) (PLGA-NPs) with encapsulated perfluoro-15-crown-5-ether and the near-infrared fluorescent dye indocyanine green. PROCEDURES: One thousand and three thousand bioluminescent PIs were transplanted into subcutaneous artificial scaffolds, which served as an alternative transplant site. The grafts were monitored using in vivo F-19 MR, fluorescence, and bioluminescence imaging in healthy rats for 2 weeks. RESULTS: Transplanted PIs were unambiguously localized in the scaffolds by F-19 MRI throughout the whole experiment. Fluorescence was detected in the first 4 days after transplantation only. Importantly, in vivo bioluminescence correlated with the F-19 MRI signal. CONCLUSIONS: We developed a trimodal imaging platform for in vivo examination of transplanted PIs. Fluorescence imaging revealed instability of the fluorescent dye and its limited applicability for longitudinal in vivo studies. A correlation between the bioluminescence signal and the F-19 MRI signal indicated the fast clearance of PLGA-NPs from the transplantation site after cell death, which addresses a major issue with intracellular imaging labels. Therefore, the proposed PLGA-NP platform is reliable for reflecting the status of transplanted PIs in vivo.

Center for Advanced Preclinical Imaging 1st Faculty of Medicine Charles University Prague Czech Republic

Centre of Experimental Medicine Institute for Clinical and Experimental Medicine Prague Czech Republic

Department of Clinical and Transplant Pathology Institute for Clinical and Experimental Medicine Prague Czech Republic

Department of Pathology 3rd Faculty of Medicine Charles University Prague Czech Republic

Department of Tumor Immunology Radboud University Medical Center Nijmegen Netherlands

Diabetes Centre Institute for Clinical and Experimental Medicine Prague Czech Republic

Institute of Biophysics and Informatics 1st Faculty of Medicine Charles University Prague Prague Czech Republic

MR Unit Department of Radiodiagnostic and Interventional Radiology Institute for Clinical and Experimental Medicine Prague Czech Republic

Zobrazit více v PubMed

Emamaullee J, Shapiro A. Factors influencing the loss of beta-cell mass in islet transplantation. Cell Transplant. 2007;16:1–8. doi: 10.3727/000000007783464461. PubMed DOI

Cantarelli E, Piemonti L. Alternative transplantation sites for pancreatic islet grafts. Curr Diab Rep. 2011;11:364–374. doi: 10.1007/s11892-011-0216-9. PubMed DOI

Kříž J, Greg V, Mazzuca DM, et al. A novel technique for the transplantation of pancreatic islets within a vascularized device into the greater omentum to achieve insulin independence. Am J Surg. 2012;203:793–797. doi: 10.1016/j.amjsurg.2011.02.009. PubMed DOI

Gálisová A, Fábryová E, Sticová E, Kosinová L, Jirátová M, Herynek V, Berková Z, Kříž J, Hájek M, Jirák D. The optimal timing for pancreatic islet transplantation into subcutaneous scaffolds assessed by multimodal imaging. Contrast Media Mol Imaging. 2017;5418495:1–13. doi: 10.1155/2017/5418495. PubMed DOI PMC

Pileggi A, Molano RD, Ricordi C, Zahr E, Collins J, Valdes R, Inverardi L. Reversal of diabetes by pancreatic islet transplantation into a subcutaneous, neovascularized device. Transplantation. 2006;81:1318–1324. doi: 10.1097/01.tp.0000203858.41105.88. PubMed DOI

Pepper AR, Pawlick R, Gala-lopez B, et al. Diabetes is reversed in a murine model by marginal mass syngeneic islet transplantation using a subcutaneous cell pouch device. Transplantation. 2015;99:2294–2300. doi: 10.1097/TP.0000000000000864. PubMed DOI PMC

Eriksson O, Selvaraju R, Eich T, Willny M, Brismar TB, Carlbom L, Ahlström H, Tufvesson G, Lundgren T, Korsgren O. Positron emission tomography to assess the outcome of intraportal islet transplantation. Diabetes. 2016;65:2482–2489. doi: 10.2337/db16-0222. PubMed DOI PMC

Eter W, Bos D, Frielink C, et al. Graft revascularization is essential for non-invasive monitoring of transplanted islets with radiolabeled exendin. Sci Rep. 2015;5:15521. doi: 10.1038/srep15521. PubMed DOI PMC

Jirák D, Kříž J, Herynek V, et al. MRI of transplanted pancreatic islets. Magn Reson Med. 2004;52:1228–1233. doi: 10.1002/mrm.20282. PubMed DOI

Lu Y, Dang H, Middleton B, Zhang Z, Washburn L, Campbell-Thompson M, Atkinson MA, Gambhir SS, Tian J, Kaufman DL. Bioluminescent monitoring of islet graft survival after transplantation. Mol Ther. 2004;9:428–435. doi: 10.1016/j.ymthe.2004.01.008. PubMed DOI

Fowler M, Virostko J, Chen Z, Poffenberger G, Radhika A, Brissova M, Shiota M, Nicholson WE, Shi Y, Hirshberg B, Harlan DM, Jansen ED, Powers AC. Assessment of pancreatic islet mass after islet transplantation using in vivo bioluminescence imaging. Transplantation. 2005;79:768–776. doi: 10.1097/01.TP.0000152798.03204.5C. PubMed DOI

Sakata N, Goto M, Gumpei Y, Mizuma M, Motoi F, Satomi S, Unno M. Intraoperative ultrasound examination is useful for monitoring transplanted islets. Islets. 2012;4:339–342. doi: 10.4161/isl.22384. PubMed DOI PMC

Toso C, Vallee J-P, Morel P, Ris F, Demuylder-Mischler S, Lepetit-Coiffe M, Marangon N, Saudek F, James Shapiro AM, Bosco D, Berney T. Clinical magnetic resonance imaging of pancreatic islet grafts after iron nanoparticle labeling. Am J Transplant. 2008;8:701–706. doi: 10.1111/j.1600-6143.2007.02120.x. PubMed DOI

Saudek F, Jirák D, Girman P, Herynek V, Dezortová M, Kříž J, Peregrin J, Berková Z, Zacharovová K, Hájek M. Magnetic resonance imaging of pancreatic islets transplanted into the liver in humans. Transplantation. 2010;90:1602–1606. doi: 10.1097/TP.0b013e3181ffba5e. PubMed DOI

Srinivas M, Heerschap A, Ahrens E, et al. 19F MRI for quantitative in vivo cell tracking. Trends Biotechnol. 2010;28:363–370. doi: 10.1016/j.tibtech.2010.04.002. PubMed DOI PMC

Srinivas M, Boehm-Sturm P, Figdor C, et al. Labeling cells for in vivo tracking using 19F MRI. Biomaterials. 2012;33:8830–8840. doi: 10.1016/j.biomaterials.2012.08.048. PubMed DOI

Swider E, Staal AHJ, van Riessen N, et al. Design of triphasic poly(lactic-co-glycolic acid) nanoparticles containing a perfluorocarbon phase for biomedical applications. RSC Adv. 2018;8:6460–6470. doi: 10.1039/C7RA13062G. PubMed DOI PMC

Srinivas M, Cruz L, Bonetto F, et al. Customizable, multi-functional fluorocarbon nanoparticles for quantitative in vivo imaging using 19F MRI and optical imaging. Biomaterials. 2010;31:7070–7077. doi: 10.1016/j.biomaterials.2010.05.069. PubMed DOI

Ahrens E, Helfer B, O’Hanl, Schirda C. Clinical cell therapy imaging using a perfluorocarbon tracer and fluorine-19 MRI. Magn Reson Med. 2014;72:1696–1701. doi: 10.1002/mrm.25454. PubMed DOI PMC

Srinivas M, Morel PA, Ernst LA, Laidlaw DH, Ahrens ET. Fluorine-19 MRI for visualization and quantification of cell migration in a diabetes model. Magn Reson Med. 2007;58:725–734. doi: 10.1002/mrm.21352. PubMed DOI

Gaudet J, Ribot E, Chen, et al. Tracking the fate of stem cell implants with fluorine-19 MRI. PLoS One. 2015;10:e0118544. doi: 10.1371/journal.pone.0118544. PubMed DOI PMC

Constantinides C, Maguire M, McNeill E, et al. Fast, quantitative, murine cardiac 19F MRI/MRS of PFCE-labeled progenitor stem cells and macrophages at 9.4T. PLoS One. 2018;13:e0190558. doi: 10.1371/journal.pone.0190558. PubMed DOI PMC

Temme S, Bönner F, Schrader J, Flögel U. 19F magnetic resonance imaging of endogenous macrophages in inflammation. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2012;4:329–343. doi: 10.1002/wnan.1163. PubMed DOI

Barnett BP, Ruiz-Cabello J, Hota P, Ouwerkerk R, Shamblott MJ, Lauzon C, Walczak P, Gilson WD, Chacko VP, Kraitchman DL, Arepally A, Bulte JWM. Use of perfluorocarbon nanoparticles for non-invasive multimodal cell tracking of human pancreatic islets. Contrast Media Mol Imaging. 2011;6:251–259. doi: 10.1002/cmmi.424. PubMed DOI PMC

Liang S, Louchami K, Holvoet B, Verbeke R, Deroose CM, Manshian B, Soenen SJ, Lentacker I, Himmelreich U (2018) Tri-modal in vivo imaging of pancreatic islets transplanted subcutaneously in mice. Mol Imaging Biol 1–12. 10.1007/s11307-018-1192-0 PubMed

Srinivas M, Böhm-Sturm P, Aswendt M, et al. In vivo 19F MRI for cell tracking. J Vis Exp. 2013;e50802:25. PubMed PMC

Böhm-Sturm P, Aswendt M, Minassian A, et al. A multi-modality platform to image stem cell graft survival in the naïve and stroke-damaged mouse brain. Biomaterials. 2014;35:2218–2226. doi: 10.1016/j.biomaterials.2013.11.085. PubMed DOI

Kim J, Kalimuthu S, Ahn B. In vivo cell tracking with bioluminescence imaging. Nucl Med Mol Imaging. 2015;49:3–10. doi: 10.1007/s13139-014-0309-x. PubMed DOI PMC

Herynek V, Gálisová A, Srinivas M, van Dinther EAW, Kosinová L, Ruzicka J, Jirátová M, Kriz J, Jirák D. Pre-microporation improves outcome of pancreatic islet labelling for optical and 19F MR imaging. Biol Proced Online. 2017;19:6. doi: 10.1186/s12575-017-0055-4. PubMed DOI PMC

Gotoh M, Maki T, Kiyoizumi T, et al. An improved method for isolation of mouse pancreatic islets. Transplantation. 1985;40:437–438. doi: 10.1097/00007890-198510000-00018. PubMed DOI

Schneider C, Rasband W, Eliceiri K. NIH image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9:671–675. doi: 10.1038/nmeth.2089. PubMed DOI PMC

Fabryova E, Jirak D, Girman P, Zacharovova K, Galisova A, Saudek F, Kriz J. Effect of mesenchymal stem cells on the vascularization of the artificial site for islet transplantation in rats. Transplant Proc. 2014;46:1963–1966. doi: 10.1016/j.transproceed.2014.05.074. PubMed DOI

Böhm-Sturm P, Mengler L, Wecker S, Hoehn M. In vivo tracking of human neural stem cells with magnetic resonance imaging. PLoS One. 2011;6:e29040. doi: 10.1371/journal.pone.0029040. PubMed DOI PMC

Srinivas M, Tel J, Schreibelt G, Bonetto F, Cruz LJ, Amiri H, Heerschap A, Figdor CG, de Vries IJM. PLGA-encapsulated perfluorocarbon nanoparticles for simultaneous visualization of distinct cell populations by 19F MRI. Nanomedicine. 2015;10:2339–2348. doi: 10.2217/nnm.15.76. PubMed DOI

Fink C, Gaudet JM, Fox MS, et al. 19F-perfluorocarbon-labeled human peripheral blood mononuclear cells can be detected in vivo using clinical MRI parameters in a therapeutic cell setting. Sci Rep. 2018;8:590. doi: 10.1038/s41598-017-19031-0. PubMed DOI PMC

Bonetto F, Srinivas M, Heerschap A, et al. A novel 19F agent for detection and quantification of human dendritic cells using magnetic resonance imaging. Int J Cancer. 2012;129:365–373. doi: 10.1002/ijc.25672. PubMed DOI PMC

Helfer B, Balducci A, Nelson A, et al. Functional assessment of human dendritic cells labeled for in vivo 19F magnetic resonance imaging cell tracking. Cytotherapy. 2010;12:238–250. doi: 10.3109/14653240903446902. PubMed DOI PMC

Jirák D, Kříž J, Strzelecki M, et al. Monitoring the survival of islet transplants by MRI using a novel technique for their automated detection and quantification. Magn Reson Mater Physics, Biol Med. 2009;22:257–265. doi: 10.1007/s10334-009-0172-4. PubMed DOI

Liang S, Dresselaers T, Louchami K, Zhu C, Liu Y, Himmelreich U. Comparison of different compressed sensing algorithms for low SNR 19F MRI applications — imaging of transplanted pancreatic islets and cells labeled with perfluorocarbons. NMR Biomed. 2017;30:e3776. doi: 10.1002/nbm.3776. PubMed DOI

Liang S, Louchami K, Kolster H, Jacobsen A, Zhang Y, Thimm J, Sener A, Thiem J, Malaisse W, Dresselaers T, Himmelreich U. In vivo and ex vivo 19-fluorine magnetic resonance imaging and spectroscopy of beta-cells and pancreatic islets using GLUT-2 specific contrast agents. Contrast Media Mol Imaging. 2016;11:506–513. doi: 10.1002/cmmi.1712. PubMed DOI

Amiri H, Srinivas M, Veltien A, van Uden MJ, de Vries IJM, Heerschap A. Cell tracking using 19F magnetic resonance imaging: technical aspects and challenges towards clinical applications. Eur Radiol. 2015;25:726–735. doi: 10.1007/s00330-014-3474-5. PubMed DOI

Blahut J, Bernášek K, Gálisová A, Herynek V, Císařová I, Kotek J, Lang J, Matějková S, Hermann P. Paramagnetic 19F relaxation enhancement in nickel(II) complexes of N-trifluoroethyl cyclam derivatives and cell labeling for 19F MRI. Inorg Chem. 2017;56:13337–13348. doi: 10.1021/acs.inorgchem.7b02119. PubMed DOI

Bae PK, Jung J, Chung BH (2014) Highly enhanced optical properties of indocyanine green/perfluorocarbon nanoemulsions for efficient lymph node mapping using near-infrared and magnetic resonance imaging. Nano Converg. 10.1186/s40580-014-0006-6 PubMed PMC

Jacoby C, Temme S, Mayenfels F, Benoit N, Krafft MP, Schubert R, Schrader J, Flögel U. Probing different perfluorocarbons for in vivo inflammation imaging by 19F MRI: image reconstruction, biological half-lives and sensitivity. NMR Biomed. 2014;27:261–271. doi: 10.1002/nbm.3059. PubMed DOI

Cationic fluorinated micelles for cell labeling and 19F-MR imaging

Recent Advances in Metal-Organic Frameworks for Applications in Magnetic Resonance Imaging

PEG-Neridronate-Modified NaYF4:Gd3+,Yb3+,Tm3+/NaGdF4 Core-Shell Upconverting Nanoparticles for Bimodal Magnetic Resonance/Optical Luminescence Imaging

Glycogen as an advantageous polymer carrier in cancer theranostics: Straightforward in vivo evidence

Low-molecular-weight paramagnetic 19F contrast agents for fluorine magnetic resonance imaging

Fluorine polymer probes for magnetic resonance imaging: quo vadis?